Royalty Pharma acquires AMVUTTRA royalty for $310 million (Streetinsider.com) - Nov 4, 2025 - "The transaction covers AMVUTTRA sales beginning October 1, 2025, excluding fixed payments from the original Blackstone investment of $70 million....projects sales to exceed $6 billion by 2028."
Commercial • Sales projection • Amyloidosis • Cardiomyopathy
|